Sumitomo Pharma Co., Ltd. (DNPUF)
9.27
+0.86
(+10.29%)
USD |
OTCM |
Aug 25, 16:00
Sumitomo Pharma Gross Profit Margin (Quarterly) : 52.57% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 52.57% |
| March 31, 2026 | 51.43% |
| December 31, 2025 | 54.04% |
| September 30, 2025 | 61.73% |
| June 30, 2025 | 59.16% |
| March 31, 2025 | 62.45% |
| December 31, 2024 | 63.14% |
| September 30, 2024 | 58.50% |
| June 30, 2024 | 61.46% |
| March 31, 2024 | 58.02% |
| December 31, 2023 | 60.11% |
| September 30, 2023 | 61.16% |
| June 30, 2023 | 59.79% |
| March 31, 2023 | 58.91% |
| December 31, 2022 | 66.71% |
| September 30, 2022 | 70.65% |
| June 30, 2022 | 71.19% |
| March 31, 2022 | 69.29% |
| December 31, 2021 | 70.38% |
| September 30, 2021 | 76.39% |
| June 30, 2021 | 70.67% |
| March 31, 2021 | 72.79% |
| December 31, 2020 | 74.41% |
| September 30, 2020 | 72.80% |
| June 30, 2020 | 73.13% |
| Date | Value |
|---|---|
| March 31, 2020 | 71.10% |
| December 31, 2019 | 70.69% |
| September 30, 2019 | 75.84% |
| June 30, 2019 | 75.36% |
| March 31, 2019 | 74.76% |
| December 31, 2018 | 75.49% |
| September 30, 2018 | 75.80% |
| June 30, 2018 | 75.06% |
| December 31, 2017 | 74.62% |
| September 30, 2017 | 75.03% |
| June 30, 2017 | 76.34% |
| March 31, 2017 | 75.75% |
| December 31, 2016 | 75.37% |
| September 30, 2016 | 74.67% |
| June 30, 2016 | 76.88% |
| March 31, 2016 | 74.25% |
| December 31, 2015 | 74.45% |
| September 30, 2015 | 74.46% |
| June 30, 2015 | 73.15% |
| March 31, 2015 | 71.67% |
| December 31, 2014 | 73.60% |
| September 30, 2014 | 72.46% |
| June 30, 2014 | 73.16% |
| March 31, 2014 | 74.81% |
| December 31, 2013 | 73.16% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Takeda Pharmaceutical Co., Ltd. | 57.57% |
| Daiichi Sankyo Co., Ltd. | 78.37% |
| Eisai Co., Ltd. | 78.20% |
| Chugai Pharmaceutical Co., Ltd. | 69.49% |
| Santen Pharmaceutical Co., Ltd. | 54.66% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 40.88% |
| Return on Assets | 14.59% |
| Return on Invested Capital | 21.92% |
| Profit Margin (Quarterly) | 13.13% |
| Operating Margin (Quarterly) | 13.45% |
| Return on Net Operating Assets | 18.88% |